2Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis:best demonstrated practices. Kidney Int Suppl,2006, ( 103 ) :S44-54.
3Margells PJ, Kolb M, Yu L, et al. Inflammatory cytokines angiogenesis and fibrosis in the ratperitoneum. Am J Pathol,2002 160 (6) : 2285 -2294.
4Linden T, Musi B, Jarkelid K, et at. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects:a study of residual fluid and mesothelial cells. Petit Dial Int,2001,21 (6) :607-610.
5Bonder WA. Transforming growth factor-beta in disease:The dark side of tissue repair. J Clin Invest, 1992,90 : 1-7.
